The UK Atomic Energy Authority (UKAEA) has renewed its Embedded Engineering Resource Framework for another four years, helping to secure the UK’s position as a global leader in fusion energy development.
The new Horizon Europe programme will pick up where Horizon 2020 left off, with five main missions - cancer, climate change, marine environment, smart cities and food security.
Phase Three data from the UK trial shows that Novavax still works powerfully against the UK mutation, with a less intense impact on the South African mutation at 60%.
Professor Dirk Schoenmaker discusses how the world of finance is just beginning to acknowledge to the idea of sustainability - here, he explores what the future could bring.
Glen Ocsko, head of local government at Made Tech, discusses why local council departments do not need to live in constant fear of technological innovation.
Hugh Bettesworth, CEO, Mirada Medical, explores how AI autocontouring technology can help tackle the cancer care backlog as a result of the COVID-19 pandemic.
Yesterday, President Biden signed a slew of executive orders on climate change, describing the new proposals as a way to fight an "existential threat".
Professor Dr Tineke Lambooy discusses why granting legal personhood to entities of nature could enable society to protect biodiversity for future generations.
Engineers at the University of Bath have published a mathematical model that could help clinicians to safely ventilate two COVID patients on one ventilator.
Using statistics from Statista, Loadhog analysed data on global plastic production from 1950 to 2018 alongside global population figures and new laws to show exactly where we are in terms of our use of plastic.
The University of Washington found that small hydropower dams in Brazil are potentially damaging river connectivity and marine biodiversity - what's going on?
Researchers at Duke-NUS Medical School have reported that one in three adults are experiencing psychological distress related to COVID-19, including anxiety and depression.
New data from the REACT study finds that the rising infection rate has steadied a little, but there is no "sharp drop in infections" as in the first wave and the R is still high.
